Characterizing responses to CFTR-modulating drugs using rectal organoids derived from subjects with cystic fibrosis
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Characterizing responses to CFTR-modulating drugs using rectal organoids derived from subjects with cystic fibrosis
Authors
Keywords
-
Journal
Science Translational Medicine
Volume 8, Issue 344, Pages 344ra84-344ra84
Publisher
American Association for the Advancement of Science (AAAS)
Online
2016-06-24
DOI
10.1126/scitranslmed.aad8278
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Human Enteroids as a Model of Upper Small Intestinal Ion Transport Physiology and Pathophysiology
- (2016) Jennifer Foulke-Abel et al. GASTROENTEROLOGY
- Mechanosensitive activation of CFTR by increased cell volume and hydrostatic pressure but not shear stress
- (2015) Constanze Vitzthum et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Long-Term Culture of Genome-Stable Bipotent Stem Cells from Adult Human Liver
- (2015) Meritxell Huch et al. CELL
- Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR
- (2015) Claire E. Wainwright et al. NEW ENGLAND JOURNAL OF MEDICINE
- New pharmacological approaches for cystic fibrosis: Promises, progress, pitfalls
- (2015) Scott C. Bell et al. PHARMACOLOGY & THERAPEUTICS
- Efficacy and safety of ivacaftor in patients with cystic fibrosis and a non-G551D gating mutation
- (2014) Kris De Boeck et al. Journal of Cystic Fibrosis
- Cystic fibrosis genetics: from molecular understanding to clinical application
- (2014) Garry R. Cutting NATURE REVIEWS GENETICS
- Some gating potentiators, including VX-770, diminish F508-CFTR functional expression
- (2014) G. Veit et al. Science Translational Medicine
- Potentiator ivacaftor abrogates pharmacological correction of F508 CFTR in cystic fibrosis
- (2014) D. M. Cholon et al. Science Translational Medicine
- Adult Stem Cells in the Small Intestine Are Intrinsically Programmed with Their Location-Specific Function
- (2014) Sabine Middendorp et al. STEM CELLS
- A CFTR corrector (lumacaftor) and a CFTR potentiator (ivacaftor) for treatment of patients with cystic fibrosis who have a phe508del CFTR mutation: a phase 2 randomised controlled trial
- (2014) Michael P Boyle et al. Lancet Respiratory Medicine
- Effect of ivacaftor on CFTR forms with missense mutations associated with defects in protein processing or function
- (2013) Fredrick Van Goor et al. Journal of Cystic Fibrosis
- Development of a primary mouse intestinal epithelial cell monolayer culture system to evaluate factors that modulate IgA transcytosis
- (2013) C Moon et al. Mucosal Immunology
- Mechanism-based corrector combination restores ΔF508-CFTR folding and function
- (2013) Tsukasa Okiyoneda et al. Nature Chemical Biology
- Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene
- (2013) Patrick R Sosnay et al. NATURE GENETICS
- A functional CFTR assay using primary cystic fibrosis intestinal organoids
- (2013) Johanna F Dekkers et al. NATURE MEDICINE
- Growing Self-Organizing Mini-Guts from a Single Intestinal Stem Cell: Mechanism and Applications
- (2013) T. Sato et al. SCIENCE
- Ivacaftor in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del-CFTR Mutation
- (2012) Patrick A. Flume et al. CHEST
- Repeatability and bronchodilator reversibility of lung function in young children
- (2012) Samatha Sonnappa et al. EUROPEAN RESPIRATORY JOURNAL
- Utilização da técnica de resistência do interruptor na avaliação da resistência das vias aéreas em pacientes com fibrose cística
- (2012) Alessandra Rocha et al. Jornal Brasileiro de Pneumologia
- Ivacaftor potentiation of multiple CFTR channels with gating mutations
- (2012) Haihui Yu et al. Journal of Cystic Fibrosis
- Peyer's Patch M Cells Derived from Lgr5+ Stem Cells Require SpiB and Are Induced by RankL in Cultured "Miniguts"
- (2012) W. de Lau et al. MOLECULAR AND CELLULAR BIOLOGY
- Measurements of CFTR-Mediated Cl− Secretion in Human Rectal Biopsies Constitute a Robust Biomarker for Cystic Fibrosis Diagnosis and Prognosis
- (2012) Marisa Sousa et al. PLoS One
- Long-term Expansion of Epithelial Organoids From Human Colon, Adenoma, Adenocarcinoma, and Barrett's Epithelium
- (2011) Toshiro Sato et al. GASTROENTEROLOGY
- New clinical diagnostic procedures for cystic fibrosis in Europe
- (2011) K. De Boeck et al. Journal of Cystic Fibrosis
- A CFTR Potentiator in Patients with Cystic Fibrosis and theG551DMutation
- (2011) Bonnie W. Ramsey et al. NEW ENGLAND JOURNAL OF MEDICINE
- The n-of-1 clinical trial: the ultimate strategy for individualizing medicine?
- (2011) Elizabeth O Lillie et al. Personalized Medicine
- Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for theF508del-CFTRmutation
- (2011) J P Clancy et al. THORAX
- Effect of VX-770 in Persons with Cystic Fibrosis and the G551D-CFTRMutation
- (2010) Frank J. Accurso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Intestinal current measurement for diagnostic classification of patients with questionable cystic fibrosis: validation and reference data
- (2010) N. Derichs et al. THORAX
- Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche
- (2009) Toshiro Sato et al. NATURE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now